Completed
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
Type of Sarcoma:
Unresectable soft tissue sarcoma
Drug:
Gemcitabine and Docetaxel
Accrual Status:
Completed
Overall Study Principal Investigator:
Robert Maki, MD, PhD
Professor Pediatrics, Hematology & Oncology
Hofstra-Northwell School of Medicine